Beacon Pharmaceuticals PLC announcements
252 Dhaka Stock Exchange announcements for Beacon Pharmaceuticals PLC (BEACONPHAR) since 2010: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2010 (13).
- DSE NEWS: The Stock Brokers and Merchant Bankers are requested not to provide loan facilities to purchase shares of Beac
DSE NEWS: The Stock Brokers and Merchant Bankers are requested not to provide loan facilities to purchase shares of Beacon Pharmaceuticals Ltd. between 1st to 30th trading day after change of categorization of the said securities i.e. starting from 02.01.2011 as per SEC Directive No. SEC/CMRRCD/2001-43/169 dated October 01, 2009 and SEC Order No. SEC/CMRRCD/2001-50/167 dated October 01, 2009.
- The company will be placed in "Z" category from existing "N" category with effect from 02.01.2011 as the company did not
The company will be placed in "Z" category from existing "N" category with effect from 02.01.2011 as the company did not recommend any dividend for the year ended on June 30, 2010.
- Normal trading of the shares of the company will resume on 19.12.10 after Record date.
Normal trading of the shares of the company will resume on 19.12.10 after Record date.
- Trading of the shares of the company will remain suspended on record date i.e. 15.12.10.
Trading of the shares of the company will remain suspended on record date i.e. 15.12.10.
- Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle from 12.12.10 to 14.12.10. Trading of the shares of the company will remain suspended on record date i.e. 15.12.10.
- (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2010 (July'10 to Sep'10), the com
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2010 (July'10 to Sep'10), the company has reported net profit/(loss) after tax of Tk. 50.92 million with EPS of Tk. 0.23 (based on 220,000,000 no. of shares) as against Tk. (8.65) million and Tk. (0.14) (based on 60,000,000 no. of shares) respectively for the same period of the previous year.
- There will be no price limit on the trading of the shares of the company today (07.12.10) following its corporate declar
There will be no price limit on the trading of the shares of the company today (07.12.10) following its corporate declaration.
- The Board of Directors did not recommend any dividend for the year ended on June 30, 2010. Date of AGM: 30.12.10, Time:
The Board of Directors did not recommend any dividend for the year ended on June 30, 2010. Date of AGM: 30.12.10, Time: 10:30 AM, Venue: Factory Premises, Kathali, Bhaluka, Mymensingh. Record date: 15.12.10. The company has also reported EPS of Tk. 0.13, NAV per share of Tk. 12.04 and Net Operating Cash Flow per share of Tk. 0.16 for the year ended on June 30, 2010.
- (Repeat): As per decision of the Board of Directors of DSE, trading of the shares of Beacon Pharmaceuticals Limited will
(Repeat): As per decision of the Board of Directors of DSE, trading of the shares of Beacon Pharmaceuticals Limited will start at DSE today (12.08.10) under 'N' category. DSE Trading Code for Beacon Pharmaceuticals Limited is "BEACONPHAR" and DSE Company Code # 18482.
- (Repeat): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2010 (July'09 to March'10), the c
(Repeat): As per un-audited quarterly accounts for the 3rd quarter ended on 31st March 2010 (July'09 to March'10), the company has reported net profit after tax of Tk. 20.30 million with EPS of Tk. 0.11 (based on Pre-IPO paid-up shares) as against Tk. 12.42 million and Tk. 0.21 respectively for the same period of the previous year.
- (Repeat): As per un-audited half yearly accounts as on 31.12.09 (June' 09 to Dec' 09), the company has reported net prof
(Repeat): As per un-audited half yearly accounts as on 31.12.09 (June' 09 to Dec' 09), the company has reported net profit after tax of Tk. 8.11 million with EPS of Tk. 0.04 (based on Pre-IPO paid-up shares) as against Tk. 9.42 million and Tk. 0.16 respectively for the same period of the previous year.
- DSE NEWS: All the Hon'ble members are requested to trade (in case of general client's sale for Beacon Pharmaceuticals Li
DSE NEWS: All the Hon'ble members are requested to trade (in case of general client's sale for Beacon Pharmaceuticals Limited) only one market lot for each client's account. Any trade beyond the market lot may invoke penalty.
- DSE NEWS: The Stock Brokers and Merchant Bankers are requested not to provide loan facilities to purchase securities of
DSE NEWS: The Stock Brokers and Merchant Bankers are requested not to provide loan facilities to purchase securities of Beacon Pharmaceuticals Limited in between 1st to 30th trading day after listing of the said securities i.e. starting from 12.08.2010 as per SEC Directive No. SEC/CMRRCD/2001-43/169 dated October 01, 2009 and SEC Order No. SEC/CMRRCD/2001-50/167 dated October 01, 2009 respectively.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.